ARTICLE | Strategy
Shire's serial story
How Baxalta deal will help Shire evaluate new M&A opportunities
January 18, 2016 8:00 AM UTC
The most obvious benefits Shire plc expects to gain by acquiring Baxalta Inc. are a slew of new products and the cash to make subsequent acquisitions the company couldn't have made on its own.
But at least equally important to Shire is how Baxalta can help it evaluate additional deals that will help extend and grow its brand-new hematology, immunology and cancer franchises...